Home » Stocks » NNVC

NanoViricides, Inc. (NNVC)

Stock Price: $3.45 USD -0.30 (-8.00%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 36.76M
Revenue (ttm) n/a
Net Income (ttm) -13.45M
Shares Out 10.65M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $3.45
Previous Close $3.75
Change ($) -0.30
Change (%) -8.00%
Day's Open 3.69
Day's Range 3.35 - 3.76
Day's Volume 188,177
52-Week Range 1.85 - 19.20

More Stats

Market Cap 36.76M
Enterprise Value 24.19M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 10.65M
Float 9.54M
EPS (basic) -2.39
EPS (diluted) -2.39
FCF / Share -1.19
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 776,833
Short Ratio 3.01
Short % of Float 8.15%
Beta 0.67
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.91
Revenue n/a
Operating Income -8.00M
Net Income -13.45M
Free Cash Flow -6.67M
Net Cash 12.56M
Net Cash / Share 1.18
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -14.83%
ROE -83.11%
ROIC -159.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$14.50*
Low
14.5
Current: $3.45
High
14.5
Target: 14.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue----------
Operating Income-8.00-8.66-9.33-9.60-8.86-7.06-8.67-6.59-6.08-6.43
Net Income-13.45-8.42-8.56-10.30-10.72-2.20-13.60-8.88-6.21-6.48
Shares Outstanding5.623.593.253.012.882.832.562.292.141.99
Earnings Per Share-2.39-2.35-2.64-3.43-3.80-1.80-5.40-3.80-3.00-3.20
Operating Cash Flow-6.67-6.80-7.78-7.90-6.83-6.21-6.33-5.80-4.22-4.51
Capital Expenditures-0.01-0.07-0.24-0.16-0.48-6.76-5.23-0.06-0.06-0.19
Free Cash Flow-6.67-6.88-8.02-8.06-7.31-12.97-11.56-5.86-4.28-4.70
Cash & Equivalents13.712.567.0815.1024.1631.4736.7013.9214.279.22
Total Debt1.14--3.968.617.184.043.47--
Net Cash / Debt12.562.567.0811.1415.5524.2932.6610.4614.279.22
Assets23.9113.4518.5527.0036.6344.1943.8616.4115.6310.76
Liabilities2.162.850.886.6813.5912.4020.498.401.780.59
Book Value21.7610.6017.6620.3223.0531.7923.378.0113.8510.17
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name NanoViricides, Inc.
Country United States
Employees 17
CEO Anil R. Diwan

Stock Information

Ticker Symbol NNVC
Stock Exchange NYSE American
Sector Healthcare
Industry Biotechnology
Unique Identifier NYSEAMERICAN: NNVC

Description

NanoViricides, a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.